{"id":31487,"date":"2016-03-17T17:52:10","date_gmt":"2016-03-17T17:52:10","guid":{"rendered":"https:\/\/www.upjs.sk\/lekarska-fakulta\/klinika\/root\/infektologia\/vyskum\/projekty\/"},"modified":"2022-11-13T22:08:43","modified_gmt":"2022-11-13T21:08:43","slug":"projekty","status":"publish","type":"cpt_klinika","link":"https:\/\/www.upjs.sk\/lekarska-fakulta\/klinika\/infektologia\/vyskum\/projekty\/","title":{"rendered":"Projekty"},"content":{"rendered":"
Na Klinike infektol\u00f3gie a\u00a0cestovnej medic\u00edny prebiehalo rie\u0161enie nasledovn\u00fdch grantov\u00fdch \u00faloh <\/u><\/strong><\/p>\n \u00a0<\/p>\n Pracovn\u00edci kliniky sa ako spolurie\u0161itelia podie\u013eali na rie\u0161en\u00ed nasledovn\u00fdch grantov\u00fdch \u00faloh <\/strong><\/p>\n \u00a0<\/p>\n \u00da\u010das\u0165 na projektoch so \u0161truktur\u00e1lnych fondov:<\/strong><\/p>\n PROBIO – Probiotick\u00e9 mikroorganizmy a bioakt\u00edvne l\u00e1tky natur\u00e1lneho p\u00f4vodu pre zdrav\u0161iu popul\u00e1ciu Slovenska (26220220104)<\/p>\n CEMIO – Centrum excelentnosti pre v\u00fdskum faktorov ovplyv\u0148uj\u00facich zdravie so zameran\u00edm na skupinu marginalizovan\u00fdch a imunokompromitovan\u00fdch os\u00f4b (26220120058)<\/p>\n PROBIOTECH – Kompeten\u010dn\u00e9 centrum pre biomodul\u00e1tory a v\u00fd\u017eivov\u00e9 doplnky (26220220152)<\/p>\n \u00a0<\/p>\n KICM mala \u00fa\u010das\u0165 aj na klinick\u00fdch \u0161t\u00fadi\u00e1ch<\/strong><\/p>\n 2007 \u2013 2009\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 COP-CZ-01 (ML19387 Roche)<\/p>\n 2008 \u2013 2010\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 A8851019 Anidulafungin (Pfizer)<\/p>\n 2010 \u2013 2011\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EPID projekt (LF UPJ\u0160)<\/p>\n 2011\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 HepaMeta projekt (LF UPJ\u0160)<\/p>\n 2014 \u2013 2015\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MOSAIC (No.10306 AbbVie)<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":31484,"menu_order":2,"template":"","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[],"tags":[],"tax_aktuality":[],"class_list":["post-31487","cpt_klinika","type-cpt_klinika","status-publish","hentry"],"acf":{"acf_link_na_externy_obsah":""},"yoast_head":"\n\n\n
\n VEGA 1\/0050\/08<\/td>\n Epidemiologick\u00e9 a\u00a0klinick\u00e9 aspekty v\u00fdskytu a\u00a0priebehu v\u00edrusovej hepatit\u00eddy B u\u00a0tehotn\u00fdch na v\u00fdchodnom Slovensku a\u00a0vplyv gravidity na chronick\u00fa HBV infekciu.<\/td>\n<\/tr>\n \n VEGA 1\/0368\/10<\/td>\n Sledovanie vplyvu genetick\u00e9ho pozadia pacientov s chronickou hepatit\u00eddou C na \u00faspe\u0161nos\u0165 interfer\u00f3novej lie\u010dby.<\/td>\n<\/tr>\n \n VEGA 1\/1072\/12<\/td>\n V\u00fdskyt, klinick\u00e1 manifest\u00e1cia a prognostick\u00e1 z\u00e1va\u017enos\u0165 infekci\u00ed v\u00edrusmi hepatit\u00eddy B a C vo vz\u0165ahu k rizikov\u00fdm faktorom u\u00a0r\u00f3mskeho obyvate\u013estva.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n \n\n
\n VEGA1\/9330\/02<\/td>\n Infekcie nov\u00fdmi hepatotr\u00f3pnymi v\u00edrusmi, ich prevalencia a klinick\u00fd v\u00fdznam.<\/td>\n<\/tr>\n \n VEGA 1\/1408\/04<\/td>\n Soci\u00e1lno-psychologick\u00e1 anal\u00fdza rizikov\u00e9ho spr\u00e1vania sa vysoko\u0161kol\u00e1kov. Efekt\u00edvnos\u0165 prevencie drogov\u00fdch z\u00e1vislost\u00ed a\u00a0AIDS.<\/td>\n<\/tr>\n \n VEGA1\/2268\/05<\/td>\n Infekcie nov\u00fdmi hepatotropn\u00fdmi v\u00edrusmi TTV a\u00a0SENV u\u00a0pacientov s\u00a0chronickou hepatit\u00eddou B a\u00a0C a\u00a0ich vplyv na klinick\u00fd priebeh, histologick\u00fd n\u00e1lez a\u00a0efekt antiv\u00edrusovej lie\u010dby.<\/td>\n<\/tr>\n \n VEGA 1\/3367\/06<\/td>\n Skr\u00edning infekcie Chlamydia trachomatis u rizikov\u00fdch.a nerizikov\u00fdch skup\u00edn popul\u00e1cie na Slovensku.<\/td>\n<\/tr>\n \n VEGA 1\/3533\/06<\/td>\n \u0160t\u00fadium koxiel\u00f3zy u zvierat a \u013eud\u00ed na v\u00fdchodnom Slovensku.<\/td>\n<\/tr>\n \n KEGA\u00a0 005UPJ\u0160-4\/2012<\/td>\n Vzdel\u00e1vanie klinick\u00fdch odborov v pre- a post- gradu\u00e1lnej v\u00fdchove zameran\u00e9 na \u0161\u00edrenie aktu\u00e1lnych poznatkov z oblasti infek\u010dn\u00fdch chor\u00f4b pomocou n\u00e1strojov telemedic\u00edny<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n